Isochoric Pressure Based Preservation of Cells, Tissues and Organs

基于等容压的细胞、组织和器官保存

• 批准号: 9141809
• 负责人: MICHAEL John TAYLOR
• 金额: $ 22.35万
• 依托单位: SYLVATICA BIOTECH, INC.
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-01 至 2018-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9141809
• 关键词: Animals; Apoptosis; Area; Basic Science; Biocompatible Materials; Biological Preservation; Biomedical Engineering; Blood Vessels; Body Temperature; Breathing; California; Cell Death; Cell Survival; Cell Therapy; Cells; Clinical; Confounding Factors (Epidemiology); Cryopreservation; Development; Devices; Diving; Emergency Situation; Ensure; Evaluation; Fertility Agents; Figs - dietary; Fishes; Formulation; Freezing; Grant; Height; Hepatocyte; Hibernation; Hour; Human; Ice; Injury; Lead; Life; Mammals; Marketing; Measures; Medical Research; Medicine; Metabolism; Methods; Nature; Organ; Organ Preservation; Organ Transplantation; Organism; Ovary; Perfusion; Phase; Process; Protocols documentation; Quality Control; Readiness; Reconstructive Surgical Procedures; Recovery; Regenerative Medicine; Research Design; Research Personnel; Resuscitation; Series; Skin; Small Business Innovation Research Grant; Staging; Supporting Cell; System; Technology; Temperature; Testing; Thermodynamics; Time; Tissue Banking; Tissue Banks; Tissue Transplantation; Tissues; Transplantation; Trauma; Universities; Variant; Vascular Endothelial Cell; Whales; Work; animation; arctic ground squirrel; base; biological systems; cell type; clinically relevant; combinatorial; commercialization; cryobiology; design; drug discovery; experience; granulocyte; induced pluripotent stem cell; innovation; interest; novel strategies; pressure; programs; public health relevance; rate of change; repaired; scale up; spine bone structure; success; technology development; trauma care; young woman

 DESCRIPTION (provided by applicant): Preservation of living biological materials is needed for a huge range of endeavors in biomedicine, spanning medical research and drug discovery, organ and tissue transplantation, cell-based therapies, fertility and regenerative medicine, emergency preparedness, and trauma care. Cell preservation has historically relied on one-size-fits-all cryopreservation approaches that often lead to significant cell death, apoptosis and batch-to- batch variation. We propose development of technology using an approach based on nature in combination with existing preservation methods using human vascular endothelial cells. Ultimately this technology can be scaled up for tissues and possibly whole organs. Our approach is to use an isochoric (constant volume) pressure system to achieve thermodynamically stable non-frozen preservation of biological systems at high sub-zero temperatures that is augmented with solution formulations based upon strategies employed by supercooling and hibernating animals in nature. The objective of this grant is to identify cryopreservation solution formulations and protocols employing isochoric pressure (<95MPa) at temperatures ranging from -5 to -20°C that are compatible with cell survival under these conditions. The work is divided into 3 specific aims: In aim 1 our subaward team at University of California, Berkeley, will perform thermodynamic profiling of a series of candidate cryostasis cocktails and protocols that will limit pressure to <95MPa and allow cooling to temperatures as low as -20°C without complete freezing. In aim 2 the lead conditions that ensures a potential non-frozen state will be evaluated with human vascular endothelial cells using a combinatorial, high throughput approach. Finally, in aim 3 the newly defined cryostasis cocktails and optimal cooling/warming rates from the earlier aims will be used to test cell recovery after isochoric storage as a function of temperature, pressure and storage duration. Following demonstration of feasibility using this innovative approach to cryopreservation we will plan Phase II SBIR studies in which further optimization is performed and cryopreservation of various cells, tissues and organs of research and medical interest are evaluated using our technology.

 描述(申请人提供)：在生物医学、医学研究和药物发现、器官和组织移植、基于细胞的治疗、生育和再生医学、应急准备和创伤护理等领域的广泛努力中，需要保存活的生物材料。细胞保存在历史上依赖于一刀切的冷冻保存方法，这种方法往往会导致显著的细胞死亡、凋亡和批次之间的差异。我们建议使用一种基于自然的方法结合现有的使用人类血管内皮细胞的保存方法来开发技术。最终，这项技术可以扩大到组织，甚至整个器官。我们的方法是使用等容(恒定体积)压力系统来实现在零度以下的高温下生物系统的热力学稳定的非冷冻保存，并根据自然界中过冷和冬眠动物所采用的策略添加溶液配方。这笔赠款的目标是确定在-5至-20°C的温度范围内使用等容压力(&lt；95 Mpa)的低温保存溶液配方和方案，以适应这些条件下的细胞存活。这项工作分为3个具体目标：在目标1中，我们在加州大学伯克利分校的分奖团队将对一系列候选低温鸡尾酒和方案进行热力学分析，这些方案将把压力限制在95兆帕，并允许在不完全冻结的情况下冷却到-20°C的温度。在目标2中，将使用组合的高通量方法用人类血管内皮细胞评估确保潜在非冰冻状态的铅条件。最后，在目标3中，新定义的低温鸡尾酒和早期目标的最佳冷却/升温速率将用于测试等容储存后电池的恢复情况，作为温度、压力和储存时间的函数。在证明了使用这种创新的方法进行冷冻保存的可行性后，我们将计划进行第二阶段的SBIR研究，在该阶段中，将进行进一步的优化，并使用我们的技术评估各种研究和医学兴趣的细胞、组织和器官的冷冻保存。